Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
New Drug Targets
100%
Therapeutic Biomarkers
100%
Chronic Graft-versus-host Disease (cGVHD)
100%
Graft-versus-host Disease (GvHD)
60%
Gastrointestinal Tract
40%
Patient Will
40%
Infection Risk
20%
Therapeutic Target
20%
Cell Survival
20%
T Cells
20%
Mechanism of Action
20%
Clinical High Risk
20%
Immunosuppression
20%
PubMed
20%
Response to Therapy
20%
Expert Opinion
20%
Relapse Risk
20%
Search Terms
20%
Disease Treatment
20%
Target Organ
20%
Refractory Patients
20%
Patient Response
20%
Area Cover
20%
Grading System
20%
Ongoing Clinical Trials
20%
Risk-adapted Therapy
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Systemic Steroids
20%
Selective Targeting
20%
Steroid-refractory
20%
Search Keywords
20%
Integrin Receptor
20%
Host Treatment
20%
Clinical Grading
20%
Various Approaches
20%
Action Target
20%
Emerging Therapeutic Targets
20%
JAK Signalling
20%
Avoid Risks
20%
Immunology and Microbiology
Acute Graft Versus Host Disease
100%
Therapeutic Target
100%
Graft-Versus-Host Disease
80%
Gastrointestinal Tract
40%
Steroid
40%
T Cell
20%
Cell Survival
20%
Immunosuppression
20%
Infectious Disease
20%
Target Cell
20%
Hematopoietic Cell
20%
Target Organ
20%
Cell Transplantation
20%
Integrin
20%
Infection
20%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Acute Graft Versus Host Disease
100%
Graft Versus Host Reaction
40%
Steroids
40%
Clinical Trial
20%
Infection
20%
Integrin Receptor
20%